{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:05:46Z","timestamp":1792994746897,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jaad.2021.11.014","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T20:46:55Z","timestamp":1637182015000},"page":"835-845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Real-world comorbidities of atopic dermatitis in the US adult ambulatory population"],"prefix":"10.1016","volume":"86","author":[{"given":"Youkyung S.","family":"Roh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishadh","family":"Sutaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Wongvibulsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary A.","family":"Bordeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Canner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Grossberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2021.11.014_bib1","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaci.2013.08.031","article-title":"Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study","volume":"132","author":"Silverberg","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib2","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC phase three","volume":"124","author":"Odhiambo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2021.11.014_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jid.2020.08.020","article-title":"Health-related QOL and economic burden of chronic pruritus","volume":"141","author":"Whang","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib6","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaip.2017.10.024","article-title":"Health care resource utilization and costs among adults with atopic dermatitis in the United States: a claims-based analysis","volume":"6","author":"Drucker","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaad.2021.11.014_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/jdv.14523","article-title":"The impact of atopic dermatitis on work life \u2013 a systematic review","volume":"32","author":"N\u00f8rreslet","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2021.11.014_bib8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s12325-021-01630-z","article-title":"Psychosocial comorbidities and health status among adults with moderate-to-severe atopic dermatitis: a 2017 US National Health and Wellness Survey analysis","volume":"38","author":"Kwatra","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaad.2021.11.014_bib9","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2013.446","article-title":"The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions","volume":"134","author":"Hay","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib10","first-page":"1712","article-title":"Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity","volume":"6","author":"Vekaria","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.jaad.2021.11.014_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaad.2020.08.059","article-title":"Sleep disturbance in adults with chronic pruritic dermatoses is associated with increased C-reactive protein levels","volume":"84","author":"Patel","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/DER.0000000000000418","article-title":"Atopic dermatitis and hospitalization for mental health disorders in the United States","volume":"30","author":"Hsu","year":"2019","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaad.2021.11.014_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40257-017-0293-x","article-title":"Association between inflammatory skin disease and cardiovascular and cerebrovascular co-morbidities in US adults: analysis of nationwide inpatient sample data","volume":"18","author":"Kwa","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.anai.2017.10.019","article-title":"Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults","volume":"120","author":"Narla","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaad.2018.09.025","article-title":"Association between atopic dermatitis and autoimmune disorders in US adults and children: a cross-sectional study","volume":"80","author":"Narla","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib16","doi-asserted-by":"crossref","first-page":"e0210517","DOI":"10.1371\/journal.pone.0210517","article-title":"Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis","volume":"14","author":"Armstrong","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2021.11.014_bib17","first-page":"778","article-title":"Economic burden of atopic manifestations in patients with atopic dermatitis\u2013analysis of administrative claims","volume":"13","author":"Suh","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jaad.2021.11.014_bib18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jaad.2021.03.016","article-title":"Real-world comorbidities of atopic dermatitis in the pediatric ambulatory population in the United States","volume":"85","author":"Huang","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/jdv.15424","article-title":"Demographics, healthcare utilization and drug use in children and adults with atopic dermatitis in Denmark: a population-based cross-sectional study","volume":"33","author":"Andersen","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2021.11.014_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.anai.2020.07.026","article-title":"Real-world persistence with dupilumab among adults with atopic dermatitis","volume":"126","author":"Silverberg","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1080\/13696998.2018.1470520","article-title":"Topical treatment utilization for patients with\u00a0atopic dermatitis in the United States, and budget impact analysis of crisaborole ointment, 2","volume":"21","author":"Clark","year":"2018","journal-title":"J Med Econ"},{"key":"10.1016\/j.jaad.2021.11.014_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1536867X0900900402","article-title":"CEM: coarsened exact matching in Stata","volume":"9","author":"Blackwell","year":"2009","journal-title":"Stata J"},{"key":"10.1016\/j.jaad.2021.11.014_bib23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.21037\/jtd.2017.05.34","article-title":"A general introduction to adjustment for multiple comparisons","volume":"9","author":"Chen","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jaad.2021.11.014_bib24","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jaad.2018.08.063","article-title":"Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis","volume":"80","author":"Patel","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2018.03.017","article-title":"Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis","volume":"79","author":"R\u00f8nnstad","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2017.04.019","article-title":"Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey","volume":"77","author":"Eckert","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamadermatol.2018.1572","article-title":"Association of inadequately controlled disease and disease severity with patient-reported disease burden in adults with atopic dermatitis","volume":"154","author":"Simpson","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2018.08.005","article-title":"Sleep disorders and atopic dermatitis: a 2-way street?","volume":"142","author":"Chang","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13555-017-0192-3","article-title":"Frequency and management of sleep disturbance in adults with atopic dermatitis: a systematic review","volume":"7","author":"Jeon","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2021.11.014_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/jid.2014.325","article-title":"Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study","volume":"135","author":"Silverberg","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaad.2016.09.021","article-title":"Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: the PeDRA TREAT survey","volume":"76","author":"Totri","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases","volume":"365","author":"Irvine","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2021.11.014_bib34","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","article-title":"The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies","volume":"139","author":"Brunner","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.iac.2016.08.015","article-title":"Infectious complications in atopic dermatitis","volume":"37","author":"Sun","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaad.2021.11.014_bib36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12016-016-8548-5","article-title":"Bacterial and viral infections in atopic dermatitis: a comprehensive review","volume":"51","author":"Ong","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/bjd.14708","article-title":"Association between atopic dermatitis and extracutaneous infections in US adults","volume":"176","author":"Strom","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-319-64804-0_5","article-title":"Atopic dermatitis disease complications","volume":"1027","author":"Ashbaugh","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaad.2021.11.014_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2016.08.047","article-title":"Autoimmune diseases in adults with atopic dermatitis","volume":"76","author":"Andersen","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib40","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2012.02.002","article-title":"Does \u201cautoreactivity\u201d play a role in atopic dermatitis?","volume":"129","author":"Tang","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.jaad.2021.11.014_bib42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.anai.2017.10.037","article-title":"The atopic march: critical evidence and clinical relevance","volume":"120","author":"Hill","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4168\/aair.2011.3.2.67","article-title":"The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma","volume":"3","author":"Zheng","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaad.2021.11.014_bib44","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaip.2018.10.009","article-title":"Atopic dermatitis is associated with increased prevalence of multiple ocular comorbidities","volume":"7","author":"Govind","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaad.2021.11.014_bib45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40257-019-00455-5","article-title":"Ocular co-morbidities of atopic dermatitis. Part I: associated ocular diseases","volume":"20","author":"Beck","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib46","first-page":"189","article-title":"Ocular complications of atopic dermatitis","volume":"104","author":"Hsu","year":"2019","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2021.11.014_bib47","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0161-6420(00)00406-1","article-title":"A high incidence of Staphylococcus aureus colonization in the external eyes of patients with atopic dermatitis","volume":"107","author":"Nakata","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2021.11.014_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjd.17869","article-title":"Conjunctivitis in dupilumab clinical trials","volume":"181","author":"Akinlade","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","article-title":"Increasing comorbidities suggest that atopic dermatitis is a systemic disorder","volume":"137","author":"Brunner","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib50","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12685","article-title":"Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies","volume":"70","author":"Silverberg","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2021.11.014_bib51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaci.2016.01.015","article-title":"Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis","volume":"138","author":"Andersen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2021.11.014_bib52","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jid.2016.04.025","article-title":"Atopic dermatitis is associated with less physical activity in US adults","volume":"136","author":"Silverberg","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib53","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jaad.2015.02.1116","article-title":"Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis","volume":"72","author":"Legendre","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/11593280-000000000-00000","article-title":"Atopic dermatitis and risk of skin cancer: a Danish nationwide cohort study (1977-2006)","volume":"13","author":"Jensen","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2021.11.014_bib55","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1158\/1055-9965.EPI-14-1243","article-title":"History of allergy and atopic dermatitis in relation to squamous cell and basal cell carcinoma of the skin","volume":"24","author":"Cheng","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2021.11.014_bib56","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2340\/00015555-2703","article-title":"Prevalence of cancer in adult patients with atopic dermatitis: a nationwide study","volume":"97","author":"Ruff","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2021.11.014_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jdermsci.2016.07.009","article-title":"Atopic dermatitis, naevi count and skin cancer risk: a meta-analysis","volume":"84","author":"Gandini","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2021.11.014_bib58","first-page":"708","article-title":"Atopic dermatitis is not a protective factor for melanoma but asthma may be","volume":"19","author":"Hajdarbegovic","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jaad.2021.11.014_bib59","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1468-3083.2008.02888.x","article-title":"Low risk of melanoma in patients with atopic dermatitis","volume":"22","author":"Synnerstad","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221028383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221028383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:01:27Z","timestamp":1759273287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221028383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0190962221028383"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.11.014","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world comorbidities of atopic dermatitis in the US adult ambulatory population","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}